INSIGHT INTO INNOVATIONS: Diabetes And Heart Failure Come Under Spotlight
This article was originally published in Clinica
Medtech start-ups continue to bring fresh ideas and new approaches to a market that is continually looking for better and cheaper treatment options. The medical device industry’s major trade association, Advamed, featured dozens of start-ups at its annual conference in October, and companies offering new solutions to battle chronic diseases were among the highlights
You may also be interested in...
Deal Snapshot: AstraZeneca has sublicensed global rights to its peripheral mu-opioid receptor antagonist to RedHill Biopharma, excluding Europe, Canada and Israel, with RedHill also separately receiving non-dilutive financing from HealthCare Royalty Partners.
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.